Introduction
Ischaemia detection is of importance in the management of patients with suspected coronary artery disease (CAD) 1 and quantitative assessment of myocardial blood flow (MBF) with positron emission tomography (PET) is considered the current non-invasive gold standard for this purpose. 2 Despite the excellent diagnostic value of PETdefined hyperaemic MBF and myocardial flow reserve, 2 reductions in these regional flow parameters are considered relatively non-specific as they can be a consequence of both the flow-limiting effects of an epicardial stenosis and microvascular dysfunction. 3 Several studies have reported on the relationship between CAD and the longitudinal flow gradient, an abnormal decrease in hyperaemic MBF from the base to the apex of the left ventricle. [4] [5] [6] [7] [8] While initial reports have
shown that this abnormal decrease in MBF occurs only in vessels with diffuse CAD, recent studies have reported on this phenomenon in vascular territories with a focal epicardial stenosis. [5] [6] [7] A proof-ofprinciple study has even shown a close correlation between the hyperaemic longitudinal MBF gradient and the invasively measured fractional flow reserve (FFR), a specific index for the haemodynamic consequences of an epicardial coronary stenosis. 6 The hyperaemic longitudinal MBF gradient has since been postulated as an emerging non-invasive index of haemodynamically significant CAD. 9 This study therefore aimed to investigate the diagnostic value of the hyperaemic longitudinal MBF gradient for the presence of haemodynamically significant CAD as defined by FFR. Additionally, the influence of lesion location on the relationship between longitudinal flow parameters and FFR was explored.
Methods

Study population
The current report is a substudy of the PACIFIC trial and details regarding the study design and population are described previously. 2 In brief, 208
patients with suspected CAD underwent coronary computed tomography (CT) angiography, single-photon emission computed tomography, and [
15
O]H 2 O PET imaging, followed by invasive coronary angiography with FFR measurement in all major coronary vessels. For the current analysis all patients with PET imaging were included (n = 204). In patients with a left dominant coronary anatomy in which the right coronary artery (RCA) did not subtend left ventricular (LV) myocardium, the RCA was excluded from analysis. The study protocol was approved by the Medical Ethics Committee of the VU University Medical Center and written informed consent was obtained.
Invasive coronary angiography and FFR
Invasive coronary angiography and FFR measurements were performed as described previously. 2 In brief, all major coronary arteries were routinely interrogated by FFR except for occluded or subtotal lesions > _90%. Maximal hyperaemia was induced by infusion of intracoronary (150 mg) or intravenous (140 mgÁkg -1 Ámin -1 ) adenosine. An FFR of < _0.80 was considered haemodynamically significant. In case of a missing FFR, subtotal stenoses of > _ 90% were deemed significant, whereas lesions with stenosis of < _30% (obtained with QCA) were deemed non-significant. For a subgroup analysis on the influence of lesion location, vessels were divided into three groups: vessels with a proximal stenosis of > _40%, vessels with a non-proximal stenosis of > _40%, and vessels without a stenosis of > _40%. 10, 11 Coronary lesions were deemed proximal if localized in one the following coronary segments [according to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines]: segment 12 for the left anterior descending artery (LAD), segment 18 for the left circumflex artery coronary artery (LCX), and segment 1, 2, and 3 for the RCA.
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Lesions in other segments were deemed non-proximal. Patients were scanned using a hybrid PET-CT device (Philips Gemini TF 64, Philips Healthcare, Best, The Netherlands). The scanning protocol has been described in detail previously. 13 In summary, a dy- 
Statistical analyses
All statistical analyses were performed using the SPSS software package (version 20.0.0, IBM SPSS Statistics), except for receiver-operating characteristic (ROC) curve analyses, which were performed with MedCalc for Windows (version 12.7.8.0, MedCalc Software, Oostende, Belgium). Continuous variables were tested for normal distribution. Normal distributed continuous variables are presented as mean ± standard deviation. Non-normal distributed variables are presented as median with interquartile range. Categorical variables are presented as frequencies with percentages. Continuous variables of the various PET-derived flow parameters using both Method 1 and 2 were compared between groups using Generalized Estimating Equations in order to account for multiple observations within patients. Models included a main effect for the grouping variables and an exchangeable correlation structure was used. Spearman's correlation was used to measure association between the various PETderived flow parameters and FFR and between PET-derived flow parameters and QCA stenosis grade. ROC curve analysis was performed to determine optimal cut-off values for the hyperaemic MBF, hyperaemic longitudinal MBF gradient and D longitudinal MBF gradient (by both Method 1 and 2) for the presence of haemodynamically significant CAD as defined by FFR. The diagnostic value of the hyperaemic longitudinal MBF gradient and D longitudinal MBF gradient (by both Method 1 and 2) for the presence of haemodynamically significant CAD was tested against the diagnostic value of hyperaemic MBF by comparing the ROC curve using the method of DeLong. Subgroup analyses were performed for vessels with a proximal lesion and vessels with a non-proximal lesions. Again, spearman's correlation was used in these subgroups to measure the association between the PET-derived flow parameters and FFR. A P-value <0.05 was considered statistically significant.
Results
Study population
The baseline characteristics of all 204 included patients are shown in Table 1 . Nine patients had a left-dominant coronary anatomy in which the RCA did not subtend LV myocardium. Therefore, in these nine cases the RCA was excluded from analysis. Finally, the total number of vessels included for analysis was 603 (98.5%).
Invasive coronary angiography and FFR
FFR measurements were performed in 542 (89.9%) vessels. In 58 (9.6%) vessels FFR was not performed because of the presence of a total/sub-total lesion. These vessels all showed >90% diameter stenosis and were thus deemed haemodynamically significant. Additionally, FFR measurement was not possible in 3 (0.5%) vessels because of severe tortuosity. None of these vessels showed a coronary lesion of > _30% diameter stenosis, and they were thus deemed non-obstructed. The total number of vessels with haemodynamically obstructive CAD as defined by FFR was 160 (26.5%).
[ 15 O]H 2 O PET imaging
Regional and longitudinal flow parameters stratified by FFR results are depicted in Table 2 . Mean rest MBF did not differ between vessels with and without haemodynamically significant CAD (P = 0.62). Mean hyperaemic MBF and MFR values however were significantly lower in vessels with than vessels without haemodynamically significant CAD (P < 0.001 for both). There was no significant difference between mean rest longitudinal MBF gradient by either of the two methods between vessels with and vessels without haemodynamically significant CAD (P = 0.76 for Method 1 and P = 0.38 for Method 2). Although numerically slightly lower, there were also no significant difference in mean hyperaemic longitudinal MBF gradient and mean D longitudinal MBF gradient calculated by Method 1 between vessels with and without FFR-defined haemodynamically significant CAD (P = 0.31 and P = 0.20 respectively). However, when using Method 2 both the mean hyperaemic longitudinal MBF gradient and the mean D longitudinal MBF gradient were significantly lower in vessels with than vessels without haemodynamically significant CAD (P < 0.001 for both). Figure 2 shows the relationship of the various longitudinal flow parameters with FFR. A significant but weak correlation was found between hyperaemic longitudinal MBF gradient and FFR calculated by Method 1 (r = 0.10, P = 0.02). D Longitudinal MBF gradient and FFR however were not significantly correlated (r = 0.08, P = 0.052). For Method 2, a significant but fairly weak correlation was found between hyperaemic longitudinal MBF gradient and FFR (r = 0.22, P < 0.001) and between D longitudinal MBF gradient and FFR (r = 0.21, P < 0.001). Figure 3 shows the relationship between the various longitudinal MBF gradient parameters and QCA stenosis grade. For Method 1, no significant correlation was noted between hyperaemic longitudinal MBF gradient (r = -0.07, P = 0.11) and QCA stenosis grade and between D longitudinal MBF gradient and QCA stenosis grade (r = -0.09, P = 0.06). For Method 2, a significant but weak correlation was noted between hyperaemic longitudinal MBF gradient and QCA stenosis grade (r = -0.20, P < 0.001) and between D hyperaemic longitudinal MBF gradient and QCA stenosis grade (r = -0.21, P < 0.001).
Diagnostic value of longitudinal flow parameters
The results of the ROC analysis on the diagnostic value of the different PET perfusion parameters is illustrated in Figure 4 . Sensitivity, specificity, negative predictive value, positive predictive value, and diagnostic accuracy of hyperaemic MBF, hyperaemic longitudinal MBF gradient, and D longitudinal MBF gradient (by both methods) and the addition of hyperaemic longitudinal MBF gradient to hyperaemic MBF for the presence of haemodynamically significant CAD are shown in Table 3 . The diagnostic value of hyperaemic longitudinal MBF gradient and D longitudinal MBF gradient (by both methods) for the presence of haemodynamically significant CAD were tested against the diagnostic value of hyperaemic MBF. For both methods, diagnostic value of hyperaemic longitudinal MBF gradient and D longitudinal MBF gradient were significantly smaller than that of hyperaemic MBF (P < 0.001 for all). Interestingly, longitudinal flow parameters calculated by Method 2 had significantly greater diagnostic value than those calculated by Method 1 (P < 0.001 for all).
Subgroup analysis on the influence of lesion location on longitudinal flow parameters
To test the influence of coronary lesion location on the relationship between longitudinal flow parameters and FFR, subgroup analyses was performed in patients with proximal (n = 176) and non-proximal in these subgroups are illustrated in Figure 5 . No significant correlation between longitudinal flow parameters and FFR was found in vascular territories with proximal lesions. However, significant and relatively strong correlations were found between hyperaemic longitudinal MBF gradient and FFR (r = 0.57, P < 0.001) and between D longitudinal MBF gradient and FFR (r = 0.55, P < 0.001) in nonproximal lesion. When using Method 1 for longitudinal flow gradient calculation, similar results are found. Again, no correlation was found in proximal lesions between hyperaemic longitudinal MBF gradient and FFR (r = -0.037, P = 0.68) and D longitudinal MBF gradient and FFR (r = -0.043, P = 0.640). In non-proximal lesions however, both hyperaemic longitudinal MBF gradient (r = 0.36, P = 0.003) and D longitudinal MBF gradient (r = 0.32, P = 0.008) were significantly correlated with FFR.
Discussion
Our study evaluated the diagnostic value of longitudinal flow parameters by two different methods for the presence of haemodynamically significant CAD. Results show that hyperaemic longitudinal MBF gradient and D longitudinal MBF gradient, by both methods, had lower diagnostic value when compared with hyperaemic MBF for the presence of haemodynamically significant CAD. Furthermore, subgroup analysis showed an important influence of lesion location on the relationship between longitudinal flow parameters and FFR.
The concept of the longitudinal MBF gradient is assumed to be induced by an increase in epicardial resistance during hyperaemia in vessels with CAD. [5] [6] [7] 9 In normal coronary circulation, an increase in coronary flow due to metabolic-mediated vasodilation in the microcirculation induces a flow-mediated vasodilatation of the epicardial Diagnostic value of longitudinal flow gradient for the presence of haemodynamically significant CAD coronary artery. This mechanism reduces the velocity-induced resistance, thereby ascertaining the maintenance of low coronary resistance in the epicardial conductance vessels. 15 The presence of diffuse CAD or advanced focal CAD lesions is suggested to impair this flowinduced and endothelium dependent vasodilation of the epicardial vessel. [5] [6] [7] 9 This will lead to an increase in epicardial resistance, accompanied by continuous decrease in intracoronary pressure from proximal to distal. 4 The decrease in pressure in the course of the epicardial artery is considered to account for the longitudinal MBF gradient. Gould et al. 7 were the first to report on the relationship between the longitudinal flow gradient and CAD. In a large cohort of 1001 patients, the authors showed that in patients with diffuse CAD, there was a graded decrease in longitudinal base-to-apex perfusion. More recently, Valenta et al. 5, 6 reported that this decrease in longitudinal hyperaemic myocardial perfusion is also present in advanced focal lesions. The authors conducted two separate studies with 13 N-ammonia PET imaging in which they defined the longitudinal MBF gradient as the difference between the MBFs of the mid and apical LV segments. The basal segments and the apex were excluded from analysis to avoid inaccurate MBF measurements due to count variability and partial volume effects. In these studies, the longitudinal MBF gradient and the D longitudinal MBF gradient were highly related to both stenosis severity 5 and to FFR. 6 The authors subsequently proposed the hyperaemic longitudinal MBF gradient as a novel index to identify the flow-limiting effects of coronary lesions. 9 Our results however are in contrast with these findings. When using the same methodology to calculate the longitudinal MBF gradient (Method 1), there was only a very weak correlation between the hyperaemic longitudinal MBF gradient and FFR and no correlation between the hyperaemic longitudinal MBF gradient and QCA stenosis grade. Furthermore, diagnostic value for the presence of haemodynamically obstructive CAD was lower for the longitudinal MBF gradient when compared with diagnostic value of hyperaemic MBF alone. To improve accuracy of the longitudinal flow gradient in our study, the gradient was measured over a longer longitudinal distance: from basal to apical segments (Method 2). Using this methodology, correlation with FFR and QCA was slightly better, however still relatively poor. Although diagnostic value of the longitudinal MBF gradient calculated with Method 2 for the presence of haemodynamically significant lesions was significantly greater than that of the gradient calculated with Method 1, it was still inferior to the diagnostic value of hyperaemic MBF.
Several factors may have contributed to these apparently conflicting findings. First, in the current study [ O]H 2 O is metabolically inert and freely diffusible across myocyte membrane, and therefore, uptake in/and clearance from the myocardium are linear to perfusion. 16 It is thus considered the optimal tracer for quantification of MBF.
13
N-ammonia PET on the other hand is 17 found no correlation between longitudinal MBF gradient and coronary calcium score. Second, the pathophysiological mechanism underlying the presence of a longitudinal MBF gradient in vessels with high-grade focal lesions is not fully understood. Several studies have suggested that impairment of the flow-induced and endothelium dependent vasodilation of the epicardial vessel causes a graded pressure fall along the artery which in turn causes the gradual base-to-apex MBF gradient. [5] [6] [7] 9 Whereas this theory has been tested in vessels with diffuse CAD 4,7 it remains unclear why flow-induced vasodilation of the epicardial vessel would be specifically impaired in vessels with FFRpositive lesions, compared with vessels with FFR-negative high-grade lesions. Further studies are warranted to clarify the potential physiological concept underlying the longitudinal MBF gradient in high grade lesions. Third, there are important differences in study population and design between studies. Our study population comprised a large clinical cohort of consecutive patients with suspected CAD referred for angiography in whom all major coronary arteries were routinely interrogated by FFR. Patient populations in the previous studies, however were much smaller and inclusion criteria were more selective. In both studies by Valenta et al. 5, 6 only vessels with lesions in the proximal or mid segment of the coronary artery were included.
To explore the effect of these differences in study population, the influence of coronary lesion location on the diagnostic value of the longitudinal flow parameters was tested in the current report. In vessels with an angiography-defined proximal lesion, there was no significant correlation between hyperaemic longitudinal MBF gradient and FFR. However, in the subgroup of vessels with a non-proximal lesion, a significant and relatively strong correlation between hyperaemic longitudinal MBF gradient and FFR was found (r = 0.36 for Method 1 and r = 0.57 for Method 2). The presence of a correlation between hyperaemic longitudinal MBF gradient and FFR in vessels with non-proximal lesions but not in vessels with proximal lesions, might be an important factor in the discordance between the current and previous findings. When calculating the longitudinal MBF gradient in vessels with a non-proximal lesion, the apical segment, which is distal to the stenosis is normalized to the normal perfused basal/mid segment, which is proximal to the stenosis. This will logically lead to a lower longitudinal MBF gradient compared with vessels without a stenosis and compared with vessels with a proximal stenosis in which no normal perfused basal/mid segment exist for normalization. It is therefore not unanticipated that longitudinal MBF gradients in vessels with non-proximal lesions will be correlated with FFR. This concept of normalizing to a relatively normal perfused area is similar to the concept used for the relative flow reserve. In relative flow reserve measurement, the hyperaemic MBF in a stenotic area is normalized to hyperaemic MBF in a normal perfused area. 18 This commonly used perfusion index has been shown to be highly correlated with FFR, although it may be not superior to hyperaemic MBF in [ 
Limitations
This study has several limitations. First, although an effort was made to improve accuracy of the longitudinal MBF gradient by incorporating the basal MBF values in the calculation of Method 2, the perfusion of the apex was not used for calculation. In theory, this may have led to underestimation of the longitudinal MBF gradient. Furthermore, the more elaborate approach by Gould et al. 7 in which the relative tracer activity was measured in 34 tomographic slices generated by a 3D restructuring algorithm would also potentially have yielded different results. Third, count variability in the basal segments may have influenced the calculation of the longitudinal MBF gradient by Method 2. This may have hampered the diagnostic value for the presence of haemodynamically obstructive CAD. Fourth, since standard segmentation according to the American Heart Association was used to assign coronary arteries to PET perfusion territories, some mismatch may have occurred. Prior studies however have reported that mismatch is uncommon and that standard segmentation yields similar results compared with the individualized approach in which angiography is used to assign arteries to perfusion territories. 22 Nonetheless, since calculation of the longitudinal MBF gradient is based on MBF values in a smaller number of segments, mismatch may have affected our results. Fifth, the subgroup analysis on the influence of lesion location was hampered by the relatively small sample size of 126 proximal lesions and 69 non-proximal lesions in which FFR measurements were available. Furthermore, although care was taken to establish lesion location based on invasive angiography, lesion location was simplified for analysis into proximal or nonproximal. The influence of exact lesion location on longitudinal flow measurements was not determined in this study. Differences in lesion location, patient population, and tracer kinetics may hamper comparison with prior studies and therefore care must be taken when interpreting our results.
Conclusion
In this study, the current methodology of PET-measured longitudinal flow parameters had lower diagnostic value when compared with hyperaemic MBF for the presence of haemodynamically significant CAD. Since a possible influence of lesion location on the correlation of PET measured longitudinal flow parameters with FFR was identified, presence of a longitudinal flow gradient might be partly caused by normalization to a relatively normal perfused area.
